Instituto de Química Orgánica General

Instituto de Química Orgánica General
Name	Instituto de Química Orgánica General
Native name	Instituto de Química Orgánica General
Established	1940s
Type	Research institute
Location	Madrid, Spain
Parent organization	Consejo Superior de Investigaciones Científicas

Contents

Instituto de Química Orgánica General is a research institute within the Consejo Superior de Investigaciones Científicas located in Madrid, Spain, devoted to advanced studies in organic chemistry, natural products, and chemical biology. The institute has historical ties to Spanish scientific institutions such as the Universidad Complutense de Madrid and collaborations with European centers like the Max Planck Society, the CNRS, and the European Molecular Biology Laboratory.

History

The institute was founded during the 1940s amid reorganization of Spanish science involving the Consejo Superior de Investigaciones Científicas, the Universidad de Madrid, and figures associated with the Instituto Nacional de Industria; early leadership included scientists connected to the Real Academia de Ciencias Exactas, Físicas y Naturales, the Instituto Químico de Sarriá, and the Universidad Autónoma de Madrid. Over decades the institute expanded through programs linked to the European Research Council, the Horizon 2020 framework, and bilateral agreements with institutions such as Harvard University, the University of Cambridge, and the University of Tokyo. Its evolution paralleled Spanish scientific policy shifts involving the Ministerio de Ciencia e Innovación, the Plan Nacional de I+D+i, and membership in networks including the European Chemical Society and the Federation of European Biochemical Societies.

Research emphasizes organic synthesis, natural product chemistry, and chemical biology with programs intersecting with medicinal chemistry collaborations involving Instituto de Salud Carlos III, drug discovery projects with the Pharmaceutical industry and structural studies tied to the European Synchrotron Radiation Facility, the X-ray crystallography community and the Nuclear Magnetic Resonance networks. Active topics include total synthesis of complex molecules related to projects at Scripps Research Institute, mechanistic organic chemistry connected to work at the Max Planck Institute for Coal Research, catalysis research in dialogue with the California Institute of Technology and the ETH Zurich, and computational studies referencing methods from the Max Planck Institute for Polymer Research and the European Bioinformatics Institute. Interdisciplinary efforts link to chemical ecology projects with the Royal Botanic Gardens, Kew, marine natural products collaborations with the Institute of Marine Research, and chemical proteomics initiatives associated with the Wellcome Trust and the Howard Hughes Medical Institute.

The institute maintains instrumentation comparable to core facilities at the European Molecular Biology Laboratory, including high-field Nuclear Magnetic Resonance spectrometers used in studies paralleling those at Bruker centers, mass spectrometry platforms similar to ones at the European Mass Spectrometry Center, X-ray diffractometers akin to equipment in the Diamond Light Source, and high-performance computing clusters interoperable with resources at the Barcelona Supercomputing Center. Laboratory infrastructure supports synthetic chemistry suites, biological containment areas developed with standards from the World Health Organization, and spectroscopy rooms often involved in joint projects with groups from the Max Planck Society and the Centre National de la Recherche Scientifique.

The institute hosts postgraduate programs in collaboration with the Universidad Complutense de Madrid, the Universidad Autónoma de Madrid, and international graduate schools such as the European Molecular Biology Laboratory courses and summer schools linked to the Gordon Research Conferences. Training includes doctoral supervision aligned with doctoral programs at the Universidad de Alcalá and postdoctoral fellowships funded by the European Research Council, the Marie Skłodowska-Curie Actions, and national grants from the Ministerio de Ciencia e Innovación. Educational outreach encompasses seminars featuring speakers from institutions like the Massachusetts Institute of Technology, the University of Oxford, and the Imperial College London.

The institute engages in partnerships with national bodies including the Instituto de Salud Carlos III and international institutions such as the Max Planck Society, the CNRS, the University of California, Berkeley, the University of Cambridge, the Karolinska Institutet, and the National Institutes of Health. Industrial collaborations have included projects with multinational companies resembling alliances with GlaxoSmithKline, Novartis, and Pfizer as well as technology transfer efforts with regional innovation hubs linked to the European Institute of Innovation and Technology and the CDTI (Centro para el Desarrollo Tecnológico Industrial).

Researchers and alumni have included investigators who later affiliated with institutions such as the Universidad Complutense de Madrid, the Universitat de Barcelona, the Max Planck Society, the Scripps Research Institute, and the University of Cambridge. Alumni have gone on to positions in organizations like the European Commission research services, the World Health Organization, and industry leadership roles at companies comparable to Roche and AstraZeneca, and have received recognitions analogous to awards from the Real Academia de Ciencias Exactas, Físicas y Naturales and fellowships from the European Research Council.